Once-weekly survodutide linked to drop in body weight in obesity
For adults with obesity without diabetes, once-weekly survodutide, an investigational glucagon receptor-glucagon-like peptide-1 receptor dual agonist, is associated with greater reductions in body weight than placebo, according ...
Jun 10, 2026
0
3









